« Previous
Next »
Current Problems in Cancer
Volume 30, Issue 6
, Pages 283-297
, November 2006
Analyzing the “Correct” Endpoint
References
- Impacting quality of life for patients with advanced cancer with a structured multi-disciplinary intervention: a randomized controlled trial. J Clin Oncol. 2006;24:635–642
- Evaluation of shark cartilage in patients with advanced cancer. Cancer. 2005;104:176–182
- Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy. J Clin Oncol. 2005;23:2606–2617
- New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. 2000;92:205–216
- . Issues for statisticians in conducting analyses and translating results for quality of life end points in clinical trials. J Biopharm Stat. 2004;14:73–96
- . In: Analyzing quality of life (QOL) endpoints in clinical trials (via the SAS System). 1998;p. 1213–1222Proceedings of the 23rd Annual SAS Users Group International Conference
- . In: Design and analysis of cancer control studies using the SAS system (SUGI 25). 2000;p. 1356–1365Indianapolis, IN: Proceedings of the 25th Annual SAS Users Group International Conference; (paper 259-25)
- . Optimal timing for QOL assessments. Curr Probl Cancer. 2005;29:278–284
- . Clinical significance of patient-reported questionnaire data: another step toward consensus. J Clin Epidemiol. 2005;58:1217–1219
- . Presenting longitudinal data. Curr Probl Cancer. 2005;29:296–305
- . Handling missing data. Curr Probl Cancer. 2005;29:317–325
PII: S0147-0272(06)00057-2
doi: 10.1016/j.currproblcancer.2006.08.006
© 2006 Elsevier Inc. All rights reserved.
« Previous
Next »
Current Problems in Cancer
Volume 30, Issue 6
, Pages 283-297
, November 2006
